0001127602-20-031780.txt : 20201217
0001127602-20-031780.hdr.sgml : 20201217
20201217162055
ACCESSION NUMBER: 0001127602-20-031780
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20201217
DATE AS OF CHANGE: 20201217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stonehouse Jon P
CENTRAL INDEX KEY: 0001385496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 201396359
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-12-15
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001385496
Stonehouse Jon P
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
1
President & CEO
Common Stock
2020-12-15
4
M
0
134278
4.15
A
918364
D
Common Stock
2020-12-15
4
S
0
134278
8.32
D
784086
D
Emp. Stock Option (Right to Buy)
4.15
2020-12-15
4
M
0
134278
0
D
2012-03-01
2021-03-01
Common Stock
134278
1
D
Emp. Stock Option (Right to Buy)
8.31
2020-12-15
4
A
0
870000
0
A
2021-12-15
2030-12-15
Common Stock
870000
870000
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020.
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.18 to $8.57. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
/s/ Alane P. Barnes, by power of attorney
2020-12-17